Clow, D W <br/><br/>
Effects of a kappa-receptor agonist, U-50,488H, on the release of endogenous brain dopamine.  [electronic resource] 

 -  Canadian journal of physiology and pharmacology  Feb 1988 
 - 128-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-4212 
<br/><br/><label>Standard No.: </label>10.1139/y88-023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer<br/>Analgesics--pharmacology<br/>Animals<br/>Azocines--pharmacology<br/>Brain--drug effects<br/>Dopamine--metabolism<br/>In Vitro Techniques<br/>Male<br/>Narcotic Antagonists--pharmacology<br/>Potassium--pharmacology<br/>Putamen--drug effects<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Rats, Inbred Strains<br/>Receptors, Opioid--drug effects<br/>Receptors, Opioid, kappa<br/>Synaptosomes--drug effects